Gageotetrin C

General Information


DRACP ID  DRACP03495

Peptide Name   Gageotetrin C

Sequence  ELLL

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03495

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  3-OH-DiMe-C12

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C23H42N4O7

Absent amino acids  ACDFGHIKMNPQRSTVWY

Common amino acids  L

Mass  54031

Pl  3.85

Basic residues  0

Acidic residues  1

Hydrophobic residues  3

Net charge  -1

Boman Index  795

Hydrophobicity  197.5

Aliphatic Index  292.5

Half Life 
  Mammalian: 1 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24502521

Title  Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis

Doi Not available

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5514

DRACP is developed by Dr.Zheng's team.